(Q45422267)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

Sébastien Lacroix-Desmazes

12 March 2020

author

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Jagadeesh Bayry

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Srini V Kaveri

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Shivashankar Othy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Fabian Käsermann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Selma Topçu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Chaitrali Saha

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Prathap Kothapalli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Sylvia Miescher

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

language of work or name

English

0 references

publication date

2 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

12 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

2059-2063

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700174%20AND%20SRC:MED&resulttype=core&format=json

Intravenous immunoglobulin: exploiting the potential of natural antibodies

12 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

Modulation of the cellular immune system by intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

What is the contents of the magic draft IVIg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

Tregitope update: mechanism of action parallels IVIg

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

A differential concentration-dependent effect of IVIg on neutrophil functions: relevance for anti-microbial and anti-inflammatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

Cutting edge: intravenous Ig inhibits invariant NKT cell-mediated allergic airway inflammation through FcγRIIIA-dependent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcγ receptor for the amelioration of experimental ITP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

DC-SIGN and alpha2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440

Long-term therapy with intravenous immunoglobulin is beneficial in patients with autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444440